IPP Bureau
USFDA approves novel, dual-targeted treatment for type 2 diabetes
By IPP Bureau - May 15, 2022
In clinical trials, treatment proved more effective than other therapies evaluated
KIMS Hospitals sign MoU with Dr Raj Nagarkar to set up a hospital at Nashik
By IPP Bureau - May 15, 2022
The new hospital is expected to open by March'24
Merck KGaA first quarter earnings grows on higher volumes, margins
By IPP Bureau - May 15, 2022
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
Sarclisa (isatuximab) combination provides unprecedented median progression-free survival
By IPP Bureau - May 15, 2022
The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone
CCMB develops India’s first mRNA vaccine technology
By IPP Bureau - May 14, 2022
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Zydus launches Bemdac to treat LDL-Cholesterol
By IPP Bureau - May 14, 2022
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business
By IPP Bureau - May 14, 2022
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
LOTTE to purchase Bristol Myers Squibb manufacturing facility in East Syracuse, New York
By IPP Bureau - May 14, 2022
East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business
Eppendorf India adds new capability at their Pipette calibration facility
By IPP Bureau - May 14, 2022
For the first time in India – fast, precise and efficient calibration of multi-channel micropipettes
Piyush Goyal invites Oman to increase pharma trade with India
By IPP Bureau - May 13, 2022
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
WHO and MPP announce agreement with NIH for Covid-19 health technologies
By IPP Bureau - May 13, 2022
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
Increased prevalence of diabetes and product innovation to boost insulin pens market in India, says GlobalData
By IPP Bureau - May 13, 2022
India has the second-largest number of adults with diabetes globally, after China
TwistPak: Mixing platform for swine vaccines brings convenience and flexibility
By IPP Bureau - May 13, 2022
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
PCI Pharma Services announces US $100 million investment in New England
By IPP Bureau - May 13, 2022
Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends
Neurocrine Biosciences receives Orphan Drug Designation for Valbenazine
By IPP Bureau - May 13, 2022
The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation
